ISSN: 2476-2067

Toxicology: Open Access
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentry   
  • Toxicol Open Access 2022 8: 175,
  • DOI: 10.4172/2476-2067.1000175

Toxicology of Anti-Diabetics Drug

James K White*
Department of Pharmacy, Harrison College of Pharmacy, Auburn University, United States
*Corresponding Author : James K White, Department of Pharmacy, Harrison College of Pharmacy, Auburn University, United States, Email: jkwhite@auburn.edu

Received Date: Feb 14, 2022 / Published Date: Mar 15, 2022

Abstract

Diabetes mellitus is the century's epidemic and diabetes continues to increase at an early phase without appropriate diagnostic techniques. Data shows that about 1 in 4 persons with this illness are unaware. Type 2 diabetes is defined as relative insulin deficiency caused by β-cells (present in the pancreas) dysfunction. It is a chronic complex disorder that requires patient self-management for control of abnormal glucose levels and continuous medical care, and multifactorial risk reduction strategies to normalize blood glucose levels, lipid profiles, and blood pressure to avert or diminish short and long term issues.

Citation: White JK (2022) Toxicology of Anti-Diabetics Drug. Toxicol Open Access 8: 175. Doi: 10.4172/2476-2067.1000175

Copyright: © 2022 White JK. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author and source are credited.

Top